Selective silencing of α-globin by the histone demethylase inhibitor IOX1: A potentially new pathway for treatment of β-thalassemia

dc.contributor.author	Mettananda, S.
dc.contributor.author	Fisher, C.A.
dc.contributor.author	Sloane-Stanley, J.A.
dc.contributor.author	Taylor, S.
dc.contributor.author	Oppermann, U.
dc.contributor.author	Gibbons, R.J.
dc.contributor.author	Higgs, D.R.
dc.date.accessioned	2016-11-25T09:30:04Z
dc.date.available	2016-11-25T09:30:04Z
dc.date.issued	2017
dc.identifier.citation	Haematologica. 2017; 102(3): e80-e84	en_US
dc.identifier.issn	0390-6078 (Print)
dc.identifier.issn	1592-8721 (Electronic)
dc.identifier.issn	0390-6078 (Linking)
dc.identifier.uri	http://repository.kln.ac.lk/handle/123456789/15252
dc.description	Indexed in MEDLINE	en_US
dc.language.iso	en_US	en_US
dc.publisher	Pavia, Italy : Ferrata Storti Foundation	en_US
dc.subject	thalassemia	en_US
dc.title	Selective silencing of α-globin by the histone demethylase inhibitor IOX1: A potentially new pathway for treatment of β-thalassemia	en_US
dc.type	Article	en_US

Files in this item

Name: full-text.pdf

Size: 1.369Mb

Format: PDF

Journal/Magazine Articles
Articles published in local and international journals by the Staff of the Faculty of Medicine